We analyzed the activity of the enhancer, the promoter and the silencer of the human CD4 gene during T cell development using transgenic mice. Immunofluorescence studies on thymic populations of mice carrying transgenes in various combinations of these regulatory DNA elements revealed that thymocytes control the CD4 gene in a different manner than mature peripheral T lymphocytes. The 5Ј-positive regulatory unit, consisting of the promoter and the 5Ј enhancer, is already active at the CD4 -CD8 -double-negative (DN) stage of development. However, its activity becomes lower in the double-positive and a fraction of the CD4 ⍣ CD8 int/-cell population, indicating that an additional enhancer, located in either the first or the third intron of the CD4 gene, is required for CD4 gene expression in this population. The other studied regulatory element is the minimal CD4 silencer which inhibits CD4 gene expression in peripheral CD8 T lymphocytes. This silencer is inactive in the most immature DN thymocytes, which probably use a distinct silencer mechanism to down-regulate CD4 gene expression. Unexpectedly, the CD4 silencer is also active in CD4 ⍣ CD8 int/-cells of the thymus, implying that an anti-silencer may be required to resume CD4 expression in this cell population. Altogether, the CD4 gene is regulated by several positive and negative regulatory mechanisms which come into play in a developmentally coordinated manner.
Introduction
αβ T lymphocytes are activated when the TCR interacts with express neither CD4 nor CD8. Upon progression to the next differentiation step, these double-negative (DN) cells turn on antigens associated with self-MHC molecules. This interaction involves engagement of CD4 or CD8 glycoproteins, both the CD4 and the CD8 genes and become doublepositive (DP) cells. DP cells start to express TCR on the cell known as co-receptor molecules. The CD4 or CD8 molecules expressed on the T cell bind to class II or class I MHC surface and undergo thymic selection, which confers self-MHC restriction and self-tolerance to the T cell repertoire molecules on the antigen-presenting cells respectively, stabilizing the interaction between the TCR and antigen-(reviewed in 3,4,6). After this process, DP cells lose one of the co-receptors and become either CD4 single-positive (SP) MHC complex (reviewed in 1) and facilitating transmission of activation signals through the tyrosine kinase lck (2) .
or CD8 SP cells and migrate into the periphery as mature T lymphocytes. These findings point out the importance of CD4 CD4 and CD8 molecules are co-expressed on the majority of thymocytes, while they are mutually exclusively expressed and CD8 in both reactivity and development of the T cell. Furthermore, they suggest that co-receptor expression may on mature peripheral T cells. During thymic development, the class of the MHC molecule interacting with the TCR on be regulated in a programmed and coordinated manner. Little is known about the molecular mechanisms controlling coimmature T cells determines the co-receptor phenotype at the mature stage (reviewed in 3,4). Furthermore, most CD4 ϩ receptor expression during development as well as those which maintain the stable CD4 or CD8 SP phenotype in cells acquire helper function, while CD8 ϩ cells frequently show cytotoxic activity (5). The biological meaning of the mature cells.
During the last few years, the CD4 promoter and enhancer concordance between the T cell functions and the co-receptor phenotype remains unclear.
were identified (7-10), but turned out to be not responsible for lineage-specific CD4 gene expression. More recently, The co-receptor phenotype changes as T lymphocytes develop in the thymus. The most immature thymocytes an intronic DNA element, characterized as a silencer, has use distinct molecular mechanisms for both positive and negative regulation of CD4 expression from those used by mature T lymphocytes.
Methods

Transgenic mice and DNA constructs
The transgenic mouse strains L, S, A, B and C were previously described, and are named according to the introduced construct (11). Briefly, the L strains were established by introducing the promoter, the enhancer, the first exon followed by the entire first intron and cDNA sequence encoding the rest of the exons of the human CD4 gene. This construct also contains a 2.5 kb sequence derived from the 5Ј part of the third intron. Construct S consists of the same elements except that the third intron and~8 kb of the first intron have been deleted. Constructs A, B and C were made by inserting fragment A, B and C into construct S respectively (Fig. 1 Immunofluorescence analysis Subsequently the cell preparations were stained with the following mAb directly labeled with FITC, phycoerythrin (PE), Red613 or biotin: mouse anti-hCD4 (B-B14; Serotec, Oxford, UK), rat anti-mouse CD4 (GK1.5; Becton Dickinson, Mountain been found to be important for lineage-specific expression of View, CA), rat anti-mouse CD8 (H53.6.7, Becton Dickinson), the CD4 gene in mature T lymphocytes of humans and mice hamster anti-mouse CD3ε (500A2; PharMingen, San Diego, (11-13). However, in these studies the activities of these CA), rat anti-mouse CD69 (PharMingen, San Diego, CA) and positive (promoter and enhancer) and negative (silencer) rat anti-mouse heat-stable antigen (HSA, CD24) (J11d, kindly elements have been examined mainly in mature T lymphoprovided by U. Staerz). Biotinylated antibodies were detected cytes, but not during thymic development.
by adding streptavidin-TriColor (Caltag, South San Francisco, In the present study, in order to address the question of CA) or streptavidin-allophycocyanin (Southern Biotechnology whether the human CD4 silencer elements control transgene Associates, Birmingham, AL). In addition, unlabeled GK1.5 expression in thymic populations in the same manner as in and H53.6.7 in combination with PE-conjugated goat anti-rat peripheral T cells, we measured human CD4 (hCD4) reporter Ig anti-serum (Southern Biotechnology Associates) were used gene expression in the thymus using the transgenic strains, to gate CD4 -CD8 -DN cells by excluding PE-positive cells. which we had used for the previous study (11). The activity Three-color and four-color flow cytometric analyses were of the human promoter and enhancer elements, which we performed on a FACScan and a FACS Vantage (Becton introduced into the transgenic constructs, has not well been Dickinson) respectively. Acquired data were analyzed with characterized in immature T lymphocytes, and hence we the Lysys II and CELLQuest programs (Becton Dickinson). included analysis of promoter/enhancer activity of the human CD4 gene in this study. We studied activity of the human CD4 Results promoter in combination with the human CD4 enhancer as the 5Ј-positive regulatory unit (PRU) in the thymus. We then DN CD3 -thymocytes use different silencing mechanisms from analyzed the repressive effect of the human CD4 silencer on those of peripheral CD8 SP cells reporter gene expression driven by the 5Ј-PRU. Transgene expression in different thymic populations according to TCR
In a previous study, we localized the human homolog of the mouse CD4 silencer to the 484 bp RsaI fragment in the first and co-receptor expression was measured by multi-color immunofluorescence. This analysis revealed that thymocytes intron of the CD4 gene in peripheral T cells (11). This DNA an intronic sequence of the hCD4 gene SP lymph node cells using FITC-conjugated B-B14.
We next analyzed CD4 ϩ CD8 ϩ DP cells, which are the most abundant cells in the thymus and represent the intermediate precursors of mature T lymphocytes. In the L strains, fragment, to which we refer as fragment A ( Fig. 1) , is functional the transgene was expressed in DP thymocytes at similarly in a CD8 lineage-specific manner. Furthermore, the lineagehigh levels as in peripheral CD4 SP T cells (Tables 1 and 2 , specific silencing activity was confined within the 190 bp and Fig. 3 ). On the contrary, the S strains showed reduced RsaI-SacII subfragment, referred to as fragment B (Fig. 1) .
transgene expression (Tables 1 and 2 , and Fig. 3 ). DP Fragment C (Fig. 1) , the other 296 bp SacII-RsaI subthymocytes from the A, B and C strains also expressed fragment, did not show the silencing activity (11). To the transgene at lower levels than peripheral CD4 SP cells address the question of whether the human CD4 regulatory (Fig. 3 ). These observations suggest that the 5Ј-PRU alone is elements control transgene expression in thymic populations insufficient for high-level expression of the CD4 gene in DP in the same manner as in peripheral T cells, we measured cells and that these immature thymocytes require a positive the reporter gene expression in the thymus using the same regulatory sequence, distinct from the 5Ј-enhancer, to maintransgenic strains. Because the transgene expression tain CD4 expression at high levels. These data also suggest depends largely on the copy number integrated in the that this DNA element may be located either in the 5Ј part of genome (Table 1) , we evaluated the transcriptional activity of the third intron, which is included in construct L, or in the first the different constructs in thymic populations by comparing intron but outside of fragment A. the expression of hCD4 in thymocytes with that in CD4 SP lymph node cells of the same animal.
Full activation of the silencer and the 5Ј-PRU in CD4 int/-CD8 ϩ We first analyzed thymic DN cells, which include both CD3 -thymocytes cells, representing the most immature T cell precursors, and
In thymic CD4 int/-CD8 ϩ cells, a weak transgene expression mature CD3 ϩ cells (either TCRαβ ϩ or γδ ϩ ). To distinguish was detected in the L, A and B strains (Fig. 4) , suggesting between these two DN populations, thymocytes were stained that the silencer is already active when the surface CD4 with anti-CD4 and anti-CD8 mAb with one color, and the protein starts to decrease. Mice with constructs S and C, negative cells were studied for expression of CD3 and hCD4 lacking the silencer sequence, expressed hCD4 in CD4 int/-( Fig. 2 and Table 2 ). In the L strains, which bear a construct with the whole first intron and a part of the third intron, the CD8 ϩ cells as strongly as in peripheral T lymphocytes ( Fig.   Fig. 2 . Two-dimensional dot-plot for CD3 and human CD4 in DN gated thymocytes. The quadrants discriminate positive and negative cells. DN cells were detected by a combination of anti-mouse CD4 and anti-mouse CD8 mAb as described. Numbers in quadrants indicate the percentage of gated cells. (Fig. 2) . The value of each peak is separately calculated. 4), indicating that the 5Ј-PRU is sufficient for full expression located in the first or in the 5Ј part of the third intron. The other 70% of this population expresses the transgene at the in this cell population.
same high levels as peripheral CD4 SP cells. Unexpectedly, High-level transgene expression in a fraction of CD4 ϩ CD8 int/-in the A and B strains, we detected only a smaller number of thymocytes requires an intronic sequence of the hCD4 gene cells with high levels of hCD4 (Fig. 5) , implying that the negative regulatory element in fragment B may also be active Thymic CD4 ϩ CD8 int/-cells of the L strains expressed the transgene at high levels, as expected (Fig. 5) . Surprisingly, in the thymic CD4 ϩ CD8 int/-population. In order to estimate developmental stage of the hCD4 lo the S and C strains showed low transgene expression (hCD4 lo ) in~30% of this population. This observation again suggests cells of the S strain, thymocytes with the CD4 ϩ CD8 int and CD4 ϩ CD8 -phenotype were separately analyzed. The proporthat, like in DP thymocytes, the expression of the CD4 gene at this stage is partially supported by an enhancer-like element tion of hCD4 lo cells in the CD4 ϩ CD8 int fraction is higher than or in the 5Ј part of the third intron, is required for CD4 expression at a high level in the DP and a fraction of CD4 ϩ CD8 int/-populations. They also imply that triple-negative thymocytes may use a silencing mechanism distinct from that of mature CD8 SP lymphocytes. The results presented in this study are consistently obtained from independent lines carrying the same transgenes, indicating that the pattern of reporter gene expression is likely due to intrinsic properties of the transgenic constructs but not to effects of integration sites of the transgenes.
Discussion
In this study we assessed the activity of the positive and negative regulatory elements of the human CD4 gene during T cell development using transgenic mice. For gene activation, chromatin structure, which determines accessibility of the regulatory element and is controlled by a locus control region. The 5Ј-PRU, consisting of the promoter and the 5Ј enhancer, is able to transcribe the reporter gene in construct S in in the CD4 ϩ CD8 -fraction (Fig 6) . We further analyzed the phenotype of the hCD4 lo cells with mAb against other differenearly thymic populations with the DN CD3 -phenotype. This indicates that the transcription factors interacting with the 5Ј-tiation markers. This cell subset expresses CD3 at similar levels as the hCD4 hi cells of the same population (Fig. 7A) .
PRU are already available in early thymocytes. These results also show that the 5Ј-PRU is accessible in this thymic populaThey also express high levels of CD69 (Fig. 7B) and have a small cell volume (Fig. 7C) . Furthermore, hCD4 lo cells belong tion. However, we cannot distinguish whether this is associated with the transgene itself or with its particular integration to the HSA hi population (Fig. 7D) . These findings suggest that the hCD4 lo cells are immature cells, but in a late stage of site. We believe that the latter case is unlikely, because we observed the same phenotype in three independent differentiation, most likely immediately preceding the mature CD4 SP cells. transgenic S strains. It is still possible that chromatin structure affects in a variable manner the accessibility of the 5Ј-PRU In conclusion, the analyses of the transgenic thymi showed that: (i) transcription factors for the 5Ј-PRU are already availin different developmental stages. This transcriptional potential of the 5Ј-PRU is not constantly able in the DN CD3 -stage, (ii) the 5Ј-PRU alone is capable of expressing the transgene only in reduced levels in a maintained throughout the thymic development. Thymic DP cells and a fraction of CD4 ϩ CD8 int/-cells from the S strains fraction of DN CD3 ϩ , the majority of DP and a fraction of CD4 ϩ CD8 int/-cells, (iii) the silencer mapped in fragment B is express reduced levels of the transgene (Figs 3 and 5) . CD4 ϩ CD8 int/-hCD4 lo cells are CD3 ϩ and CD69 ϩ (Fig. 7A  active in DN CD3 ϩ , but inactive in triple-negative thymocytes, (iv) this silencer is already active in CD8 committed late and B), indicating that they have recently been activated, possibly already undergone positive selection (14). On the thymocytes, when the CD4 protein starts to decrease, and (v) this silencer can also repress transgene expression in other hand, they appear small in size (Fig. 7C ) and express high levels of HSA (Fig. 7D) , thus displaying an immature CD4 ϩ CD8 int/-cells. These observations suggest that an additional enhancer, which may be located either in the first intron phenotype. These observations indicate that activity of the 5Ј-PRU is decreased from the DP to a stage immediately in most of the thymocytes (12). This discrepancy might be due to the different extent of deletion of the first intron of the preceding to mature CD4 SP thymocytes and suggest that constructs used in the two studies. Indeed, a sequence of 8 an additional enhancer-like element is required for normal kb is removed from the human CD4 gene in our construct S, levels of CD4 gene expression in these cell populations.
while a sequence of 6 kb is deleted from the mouse CD4 These results are consistent with the recent study which gene in the other study and therefore still containing a long showed that transgenic mice carrying the human CD4 cDNA stretch of the first intron of the mouse CD4 gene. We suggest driven by human CD4 promoter, without intron sequences, that the difference of the two studies might be explained with also express lower levels of the human CD4 protein in the deletion, in our construct S, of a region containing an immature thymocytes (15). In both studies, the activity of important enhancer-like element, which instead is included in the 5Ј-PRU was assayed by measuring surface expression the construct used in the other study. Another explanation, of the transgene products. Although it has already been which we believe is unlikely but cannot be excluded, is that demonstrated that CD4 expression is controlled at the tranan inefficient interaction occurs between human regulatory scriptional level in mature T lymphocytes (13), it still remains elements and mouse DNA binding proteins. This possibility to be determined whether, in thymocytes, the transgene is not supported by the finding that our transgenic L strains, expression is also repressed at the transcriptional level.
which have the complete first intron of the human CD4 gene, Interestingly, the CD4 ϩ CD8 int/-hCD4 lo cells share several express normal levels of the transgene. characteristics with CD4 ϩ thymocytes which express CD3
The activity of the 5Ј-PRU is also decreased in a fraction and are detected in class II MHC-deficient mice, which lack of DN CD3 ϩ cells. By analyzing the S and C strains, which mature CD4 SP cells. In these animals the thymic CD4 SP carry the transgenes lacking a large part of the first intron, cells remain immature, as a consequence of the absence of~2 0% of DN CD3 ϩ cells express decreased levels of hCD4, the MHC molecules required for further maturation. Indeed, as seen in the CD4 ϩ CD8 int/-population. Thus, this population they appear small and express decreased levels of CD8 and may represent cells at the stage equivalent to the CD3, but high levels of HSA (16), thus representing a late CD4 ϩ CD8 int/-hCD4 lo population, being direct precursors of immature population. Further studies are required to determore mature DN CD3 ϩ T cells. mine whether both types of cells belong to the same popuCuriously, in the same strains, the CD4 int/-CD8 ϩ population lation.
lacks hCD4 lo cells. This observation may indicate that differenIn apparent contrast with our results, transgenic mice tiation stages of CD8 committed cells are different from CD4 carrying a construct similar to our construct S, but with committed cells, as already suggested by several groups (17-20). elements of mouse origin, express high levels of the transgene Altogether, our study shows that the transcriptional activity of the 5Ј-PRU is fully operative at early stages of thymic development, when thymic precursor cells are still triplenegative, and is reduced from the beginning of the DP stage until the cells become SP. The period with reduced 5Ј-PRU activity includes the stage when T cells undergo positive selection and overlaps the period when DP cells downregulate CD8 expression. It remains to be determined whether the change of the 5Ј-PRU activity is instrumental for lineage commitment and whether it is due to the use of different transcription factors binding to the 5Ј-PRU or to a modification of the same factors.
The activity of the CD4 silencer on transgene expression driven by the 5Ј-PRU was then investigated in transgenic thymus carrying constructs A, B or C. We observed that in the DN thymic CD3 -and CD3 ϩ cells this silencer behaves in different ways. In triple-negative thymocytes, fragment A was partially inhibitory, while fragments B and C were inactive. In DN CD3 ϩ cells, fragments A and B were inhibitory, while fragment C was inactive. Thus, in the triple-negative population, which contains the most immature cells, the CD4 gene is repressed with different mechanisms from those used in CD8 SP cells. In contrast, more mature DN CD3 ϩ cells control the CD4 gene in a manner similar to CD8 SP cells. This is also the case with thymic γδ DN cells, which do not express fully inhibited in mature CD8 SP cells. We propose the following hypothesis to explain these results. A regulatory sequence, present in construct L but outside of fragment A, attenuates the effect of the CD4 silencer in DN, but not in (11). Our findings suggest that in this latter population, an antisilencing mechanism restores CD4 gene expression. CD8 SP cells. In DN thymocytes, complete repression of the CD4 gene is mediated by an additional negative regulatory
The present study has shown that the combination of multiple regulatory proteins controls the CD4 gene in a tissueelement, excluded from construct L. Thus, two additional elements, with opposite regulatory functions and different and stage-specific manner. This type of gene regulation is not peculiar to the CD4 gene. For example, lineage-specific locations in the CD4 locus, would be involved in the CD4 gene regulation of immature thymocytes. Alternatively, it is expression of the TCR γ gene seems to be established by enhancer-silencer interaction (21). Furthermore, YY1, a possible that the copy number of the transgene might affect the silencing activity in the thymic DN population, because transcription factor which was originally cloned and characterized as a repressor protein (22), can be converted into an the L strains carry higher copy numbers of the transgene than the A and B strains (Table 1) .
enhancer factor depending on the flanking sequence of the binding sequence (23, 24) . Thus the YY1 protein controls An additional unexpected finding of this study is that the CD4 silencer located in the first intron is not active in a CD8 genes with YY1 binding motifs in a tissue-specific manner. A third example is the regulation of Ig genes driven by the lineage-specific manner, but represses CD4 expression also in CD4 committed cells. Indeed, in both the A and B strains, octamer motif, which interacts with a panel of octamer binding proteins with various types of tissue-specificity. Oct-1, a which carry two constructs with this silencer element, the hCD4 transgene is repressed in CD4 int/-CD8 ϩ as well as ubiquitously expressed octamer binding protein, confers B cell specificity to Ig gene expression when it also binds to a in CD4 ϩ CD8 int/-populations. Therefore, it is necessary to postulate the presence of an antisilencer, capable of counter-B cell-specific co-activator protein (25, 26) . Thus, including CD4, a number of genes have been found to be regulated acting the activity of the silencer in the CD4 committed thymocyte. As a normal expression of the transgene is not by a simple on-off mechanism, but by complex interactions between several regulatory proteins. observed in the L strains, we conclude that this antisilencer element is located in the first intron, outside of fragment A.
According to our results, we propose the following model for CD4 gene regulation during T lymphocyte differentiation.
In conclusion, at least two distinct silencing mechanisms control CD4 expression during development of SP T lymphoThis model consists of six different regulatory elements, which come into play at different stages of differentiation (Fig. 8) . cytes in the thymus: (i) an early silencer for DN CD3 -thymocytes, and (ii) the late silencer active in CD8 SP thymocytes Among these six elements, the promoter and the enhancer, which constitute the 5Ј-PRU, and the late silencer have been and peripheral CD8 SP T cells as well as CD4 SP thymocytes PRU positive regulatory unit characterized (7-13, 27, 28 
